2021
DOI: 10.1016/j.amjms.2021.01.028
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Risk Factors Associated with Ambulatory Outcome in Acute Ischemic Stroke Patient Smokers Treated with Thrombolytic Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 54 publications
1
4
0
Order By: Relevance
“…Our finding that lower INR was associated with a lower stroke severity has been reported by another study [29]. While the use of warfarin, the medication for controlling coagulation by itself, is not an absolute contraindication to recombinant tissue plasminogen activator(rtPA) administration; because of increased bleeding risk, an INR of >1.7 is a contraindication for the use of rtPA for AIS patient [30][31][32][33]. Nevertheless, stroke is reported to occur in patients on warfarin despite anticoagulation [34].…”
Section: Discussionsupporting
confidence: 70%
See 1 more Smart Citation
“…Our finding that lower INR was associated with a lower stroke severity has been reported by another study [29]. While the use of warfarin, the medication for controlling coagulation by itself, is not an absolute contraindication to recombinant tissue plasminogen activator(rtPA) administration; because of increased bleeding risk, an INR of >1.7 is a contraindication for the use of rtPA for AIS patient [30][31][32][33]. Nevertheless, stroke is reported to occur in patients on warfarin despite anticoagulation [34].…”
Section: Discussionsupporting
confidence: 70%
“…Although smoking is an apparent risk factor for AIS, some studies [31,37,38]have found an association between smokers that receive thrombolytics and improved clinical outcomes. The most common critique of studies that affirm the paradox is their small sample size [39], and most metanalyses find no association between smoking status and stroke severity [40,41].…”
Section: Discussionmentioning
confidence: 99%
“…Women are more likely to present with hypertension, diabetes mellitus, and obesity [ 12 , 35 ]. In contrast, men are more likely to present with a history of heart disease, myocardial infarction, peripheral arterial disease, current smoking, and alcohol consumption [ 5 , 6 , 36 , 37 ]. Our current study found that women presenting with AIS with increased heart rate treated in the telestroke network were associated with worsening neurologic functions.…”
Section: Discussionmentioning
confidence: 99%
“…Another study found that men are three times more likely to present with improved functional outcomes with rtPA treatment than women [ 4 ]. In general, the observed gender differences have been attributed to several factors such as age [ 5 , 6 ], comorbidity [ 7 , 8 ], prestroke functional status [ 9 , 10 ], and stroke severity [ 7 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Despite substantial progress in research focusing on sex differences in comorbidities influencing outcomes in male and female post-stroke patients who smoke [1][2][3], there are still major research gaps in stroke risk factors specific for male and female smokers and obese individuals. While several studies have shown that smoking is not associated with an increase in body weight [4], smoking is known to be associated with central obesity [5,6].…”
Section: Introductionmentioning
confidence: 99%